Biotech news, white papers, reports, and events from PharmaLeaders. New content daily, on our website, and delivered right to your inbox.

US FDA approves Samsung Bioepis and Biogen’s Byooviz

The US Food and Drug Administration (FDA) has approved Samsung Bioepis and Biogen’s Byooviz (ranibizumab-nuna), a biosimilar referencing Lucentis (ranibizumab). Byooviz is an anti-vascular endothelial growth factor (VEGF) The post US FDA approves Samsung Bioepis and Biogen’s Byooviz appeared first on Pharmaceutical Business review.

Boehringer acquires Abexxa Biologics to develop novel cancer therapies

German pharmaceutical firm Boehringer Ingelheim has acquired Abexxa Biologics to expand its research efforts in cancer immunology and novel immunotherapeutic approaches. The financial details of the transaction were The post Boehringer acquires Abexxa Biologics to develop novel cancer therapies appeared first on Pharmaceutical Business review.

Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years

Pfizer and its partner BioNTech have announced positive topline results from a pivotal trial of their Covid-19 vaccine in children aged 5 to 11 years. The Phase II/III The post Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years appeared first on Pharmaceutical Business review.

AstraZeneca partners with VaxEquity on self-amplifying RNA therapeutics

AstraZeneca has entered a strategic, long-term research collaboration with biopharmaceutical firm VaxEquity to discover, develop and commercialise self-amplifying RNA (saRNA) therapeutics platform. VaxEquity was founded last year by The post AstraZeneca partners with VaxEquity on self-amplifying RNA therapeutics appeared first on Pharmaceutical Business review.

Healthcare Marketing Trends for 2019 Emphasize Better Targeting with Cost-Effective Advantages

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...

Schedule Your Personalized Marketing Technology Workshop

PharmaLeaders is pleased to provide our subscribers with a special offer from our webinar partner and presenter, Collaborative Marketing Solutions (CMS). Get your own Marketing Tech Workshop for Life Sciences: Full Day or Half Day Sessions Facilitated Exercises & Group Breakout Sessions Customer Segmentation Project Prioritization Project Implementation Roadmap Follow-on Kick-off Call